Trump administration clears the way for production of peptides like BPC-157 and TB-500

Reported by MarketWatch · Published 29 Oct 2026, 12:39 AM MYT (1 hr ago)

Image: MarketWatch

The government won’t take action against compounding pharmacies that make six of the popular wellness products.

Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at MarketWatch →

Trump administration clears the way for production of peptides like BPC-157 and TB-500

Summary

More in Markets

Wendy’s buyout offer suggests the burger chain’s overhaul could be very expensive

Healthcare stocks are on their biggest hot streak in a generation. Think twice before chasing the rally.

Bullish on Anthropic but don’t want to wait until the IPO? Here’s how you can invest today.

Micron’s stock rises after SK Hynix earnings. Here’s its next major test.

We’re spending more than $11,000 a year of our own money caring for our aging parents and loved ones

3 reasons home prices keep going up, even though fewer people are buying